| Issuer: | TiVo Inc.
|
| Size/structure: | $172.5 million of notes priced March 9, 2011; five-year, non-call, no puts
|
| Terms: | 4%, up 27.5%, priced on the rich end of talk
|
| Conversion price/ratio: | $11.16; 89.6359
|
| Bookrunner: | UBS Investment Bank
|
| Proceeds: | Fund intellectual property litigation and research and development spending and for general corporate purposes, which may include funding sales and marketing expenses, increasing working capital, making capital expenditures and potentially for strategic acquisitions
|
| • Notable because TiVo traded up to 104.75 bid, 105.75 offered on debut; had a decent stock borrow; currently trading at 111.375 and was issued at par
|
|
|
| NIELSEN HOLDINGS NV
|
| Issuer: | Nielsen Holdings NV
|
| Size/structure; | $250 million of two-year mandatory convertible subordinated bonds priced Jan. 26, 2011
|
| Terms: | 6.25%, up 20%, priced at the rich end of talk
|
| Conversion price/ratio: | $27.60; maximum ratio of 2.1739 and minimum ratio of 1.8116
|
| Bookrunners: | J.P. Morgan Securities LLC and Morgan Stanley & Co. Inc.
|
| Proceeds: | Pay down debt
|
| • Notable because the mandatories rose on their debut to 54 bid, 54.5 offered from a 50 par; favored by non-traditional convertible players; incorporated in the Netherlands with principal executive offices in New York
|
|
|
| NOVELLUS SYSTEMS INC.
|
| Issuer: | Novellus Systems Inc.
|
| Size/structure: | $700 million of 30-year senior notes priced May 5, 2011; non-call until May 21, 2021, then provisionally callable at 150%; no puts
|
| Terms: | 2.625%, up 20%, priced on the rich end of talk
|
| Conversion price/ratio: | $39.50; 25.3139
|
| Bookrunners: | J.P. Morgan Securities LLC and Bank of America Merrill Lynch
|
| Proceeds: | For share repurchase program and general corporate purposes
|
| • Notable because deal moved up to 107 with higher stock on debut; expanded on a hedged basis; M&A action at the end of the year was boost for convertible holders, trading at 121 on the back of that announcement
|
|
|
| ELECTRONIC ARTS INC.
|
| Issuer: | Electronic Arts Inc.
|
| Size/structure: | $632.5 million of senior notes priced July 15; five-year, non-call, no puts
|
| Terms: | 0.75%, up 35%, priced on the rich end of talk
|
| Conversion price/ratio: | $31.74; 31.5075
|
| Bookrunners: | J.P. Morgan Securities LLC and Morgan Stanley & Co. Inc.
|
| Proceeds: | Pay part of the company's $1.3 billion cash-and-stock offer for PopCap games Inc. and to fund convertible note hedge transactions
|
| • Notable because Electronic Arts opened higher on strong demand, closed on debut at 101.375 bid, 101.625 offered; issue is a five-year, non-call bullet of the type that convertible players like
|
|
|
| UNITED THERAPEUTICS CORP.
|
| Issuer: | United Therapeutics Corp.
|
| Size/structure: | $250 million of notes priced Oct. 12; five-year, non-call, no puts
|
| Terms: | 1%, up 20%, priced on the rich end of talk
|
| Conversion price/ratio: | $47.69; 20.9688
|
| Bookrunner: | Deutsche Bank Securities Inc.
|
| Proceeds: | Repurchase up to $300 million of common stock
|
| • Notable because United Therapeutics was the first deal to break after summer meltdown; did pretty well in the secondary market despite unimpressive terms
|
